RESUMEN
Autoimmune diseases are characterized by a breakdown of immune tolerance partly due to environmental factors. The short-chain fatty acid acetate, derived mostly from gut microbial fermentation of dietary fiber, promotes antiinflammatory Tregs and protects mice from type 1 diabetes, colitis, and allergies. Here, we show that the effects of acetate extend to another important immune subset involved in tolerance, the IL-10-producing regulatory B cells (B10 cells). Acetate directly promoted B10 cell differentiation from mouse B1a cells both in vivo and in vitro. These effects were linked to metabolic changes through the increased production of acetyl-coenzyme A, which fueled the TCA cycle and promoted posttranslational lysine acetylation. Acetate also promoted B10 cells from human blood cells through similar mechanisms. Finally, we identified that dietary fiber supplementation in healthy individuals was associated with increased blood-derived B10 cells. Direct delivery of acetate or indirect delivery via diets or bacteria that produce acetate might be a promising approach to restore B10 cells in noncommunicable diseases.
Asunto(s)
Acetatos/metabolismo , Acetatos/farmacología , Artritis Experimental/terapia , Linfocitos B Reguladores/efectos de los fármacos , Fibras de la Dieta/farmacología , Acetatos/sangre , Acetilcoenzima A/metabolismo , Acetilación , Animales , Artritis Experimental/inmunología , Linfocitos B Reguladores/fisiología , Linfocitos B Reguladores/trasplante , Diferenciación Celular/efectos de los fármacos , Ácidos Grasos Volátiles/metabolismo , Ácidos Grasos Volátiles/farmacología , Femenino , Humanos , Interleucina-10 , Masculino , Ratones Endogámicos C57BL , Ratones Mutantes , Neutrófilos/citología , Neutrófilos/efectos de los fármacos , Receptores Acoplados a Proteínas G/genéticaRESUMEN
In this report, we have addressed two questions concerning immunological memory: the way in which naive and memory T cells recirculate through the body, and the intrinsic rate of division within the naive and memory populations. We identified naive and memory T cells in sheep by their cell surface phenotype and their ability to respond to recall antigen. Memory T cells were CD2hi, CD58hi, CD44hi, CD11ahi, and CD45R-, as pertains in man. T cells that crossed from blood to the tissues of the hind leg and accumulated in the popliteal afferent lymph were all of memory phenotype. Conversely, T cells in efferent lymph, 90% of which entered the lymph node (LN) via high endothelial venules (HEV), were mostly of the naive phenotype (CD2lo, CD58lo, CD44lo, CD11alo, and CD45R+). The marked enrichment of these two phenotypes in different recirculatory compartments indicated that memory T cells selectively traffic from blood to peripheral tissues to LN (via afferent lymph), whereas naive T cells selectively traffic from blood to LN (via HEV). We argue that the differential use of these two recirculation pathways probably optimizes lymphocyte interactions with antigen. The nonrandom distribution of T cell subsets in various recirculatory compartments may be related to the relative proportion of memory cells in each subset. In particular, gamma/delta T cells in blood were almost exclusively of memory phenotype, and accumulated preferentially in afferent, but not in efferent, lymph. Finally, using the bromo-deoxyuridine labeling technique, we found that at least a sizeable proportion of memory T cells, whether in blood or afferent lymph, were a dividing population of cells, whereas naive T cells were a nondividing population. This result supports an alternative model of lymphocyte memory that assumes that maintenance of memory requires persistent antigenic stimulation.
Asunto(s)
Memoria Inmunológica , Linfocitos T/inmunología , Animales , Antígenos CD/análisis , Bromodesoxiuridina/metabolismo , Linfa/inmunología , Activación de Linfocitos , Fenotipo , OvinosRESUMEN
Chemokines and their receptors are important elements for the selective attraction of various subsets of leukocytes. To better understand the selective migration of functional subsets of T cells, chemokine receptor expression was analyzed using monoclonal antibodies, RNase protection assays, and the response to distinct chemokines. Naive T cells expressed only CXC chemokine receptor (CXCR)4, whereas the majority of memory/activated T cells expressed CXCR3, and a small proportion expressed CC chemokine receptor (CCR)3 and CCR5. When polarized T cell lines were analyzed, CXCR3 was found to be expressed at high levels on T helper cell (Th)0s and Th1s and at low levels on Th2s. In contrast, CCR3 and CCR4 were found on Th2s. This was confirmed by functional responses: only Th2s responded with an increase in [Ca2+]i to the CCR3 and CCR4 agonists eotaxin and thymus and activation regulated chemokine (TARC), whereas only Th0s and Th1s responded to low concentrations of the CXCR3 agonists IFN-gamma-inducible protein 10 (IP-10) and monokine induced by IFN-gamma (Mig). Although CCR5 was expressed on both Th1 and Th2 lines, it was absent in several Th2 clones and its expression was markedly influenced by interleukin 2. Chemokine receptor expression and association with Th1 and Th2 phenotypes was affected by other cytokines present during polarization. Transforming growth factor beta inhibited CCR3, but enhanced CCR4 and CCR7 expression, whereas interferon alpha inhibited CCR3 but upregulated CXCR3 and CCR1. These results demonstrate that chemokine receptors are markers of naive and polarized T cell subsets and suggest that flexible programs of chemokine receptor gene expression may control tissue-specific migration of effector T cells.
Asunto(s)
Receptores de Quimiocina/análisis , Células TH1/química , Células Th2/química , Calcio/metabolismo , Línea Celular , Polaridad Celular , Humanos , Memoria Inmunológica , Interferón-alfa/farmacología , Interleucina-4/biosíntesis , Receptores CCR5/análisis , Factor de Crecimiento Transformador beta/farmacologíaRESUMEN
The surface phenotypes (CD1, CD4, CD5, CD8, SBU-T19, MHC class I, MHC class II, and sIg) of cells in blood, lymph nodes, and lymph were determined to examine simultaneously the distribution of lymphocyte subsets circulating in blood, afferent lymph, and efferent lymph of a peripheral lymph node. Marked differences in the percentage of certain lymphocyte subsets were apparent within the compartments examined, suggesting that lymphocyte subsets leave the blood with differing efficiencies. Lymphocyte subsets also appeared to be extracted from the blood at different rates by lymph node as opposed to subcutaneous vascular endothelium. Endothelial cells in different vascular beds may express different numbers of molecules complementary to a set of migration-related cell surface molecules specific for each lymphocyte subset. Accordingly, the vascular endothelium would be the key factor in regulating nonrandom cell migration.
Asunto(s)
Ganglios Linfáticos/citología , Sistema Linfático/fisiología , Linfocitos/fisiología , Animales , Anticuerpos Monoclonales/inmunología , Antígenos de Diferenciación/análisis , Antígenos de Histocompatibilidad/análisis , Antígenos de Histocompatibilidad Clase II/análisis , Técnicas para Inmunoenzimas , Linfocitos/clasificación , Complejo Mayor de Histocompatibilidad , Receptores de Antígenos de Linfocitos B/análisis , OvinosRESUMEN
Chemokine receptors serve as coreceptors for HIV entry into CD4+ cells. Their expression is thought to determine the tropism of viral strains for different cell types, and also to influence susceptibility to infection and rates of disease progression. Of the chemokine receptors, CCR5 is the most important for viral transmission, since CCR5 is the principal receptor for primary, macrophage-tropic viruses, and individuals homozygous for a defective CCR5 allele (delta32/delta32) are highly resistant to infection with HIV-1. In this study, CCR5-specific mAbs were generated using transfectants expressing high levels of CCR5. The specificity of these mAbs was confirmed using a broad panel of chemokine receptor transfectants, and by their non-reactivity with T cells from delta32/delta32 individuals. CCR5 showed a distinct pattern of expression, being abundant on long-term activated, IL-2-stimulated T cells, on a subset of effector/memory T cells in blood, and on tissue macrophages. A comparison of normal and CCR5 delta32 heterozygotes revealed markedly reduced expression of CCR5 on T cells from the heterozygotes. There was considerable individual to individual variability in the expression of CCR5 on blood T cells, that related to factors other than CCR5 genotype. Low expression of CCR5 correlated with the reduced infectability of T cells with macrophage-tropic HIV-1, in vitro. Anti-CCR5 mAbs inhibited the infection of PBMC by macrophage-tropic HIV-1 in vitro, but did not inhibit infection by T cell-tropic virus. Anti-CCR5 mAbs were poor inhibitors of chemokine binding, indicating that HIV-1 and ligands bind to separate, but overlapping regions of CCR5. These results illustrate many of the important biological features of CCR5, and demonstrate the feasibility of blocking macrophage-tropic HIV-1 entry into cells with an anti-CCR5 reagent.
Asunto(s)
VIH-1/crecimiento & desarrollo , Macrófagos/microbiología , Receptores de Citocinas/metabolismo , Receptores del VIH/metabolismo , Linfocitos T/metabolismo , Alelos , Anticuerpos Monoclonales/inmunología , Células Cultivadas , Infecciones por VIH/genética , Humanos , Leucocitos/metabolismo , Receptores CCR5 , Subgrupos de Linfocitos T/metabolismoRESUMEN
CCR5 is a chemokine receptor expressed by T cells and macrophages, which also functions as the principal coreceptor for macrophage (M)-tropic strains of HIV-1. To understand the molecular basis of the binding of chemokines and HIV-1 to CCR5, we developed a number of mAbs that inhibit the various interactions of CCR5, and mapped the binding sites of these mAbs using a panel of CCR5/CCR2b chimeras. One mAb termed 2D7 completely blocked the binding and chemotaxis of the three natural chemokine ligands of CCR5, RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta, to CCR5 transfectants. This mAb was a genuine antagonist of CCR5, since it failed to stimulate an increase in intracellular calcium concentration in the CCR5 transfectants, but blocked calcium responses elicited by RANTES, MIP-1alpha, or MIP-1beta. This mAb inhibited most of the RANTES and MIP-1alpha chemotactic responses of activated T cells, but not of monocytes, suggesting differential usage of chemokine receptors by these two cell types. The 2D7 binding site mapped to the second extracellular loop of CCR5, whereas a group of mAbs that failed to block chemokine binding all mapped to the NH2-terminal region of CCR5. Efficient inhibition of an M-tropic HIV-1-derived envelope glycoprotein gp120 binding to CCR5 could be achieved with mAbs recognizing either the second extracellular loop or the NH2-terminal region, although the former showed superior inhibition. Additionally, 2D7 efficiently blocked the infectivity of several M-tropic and dual-tropic HIV-1 strains in vitro. These results suggest a complicated pattern of HIV-1 gp120 binding to different regions of CCR5, but a relatively simple pattern for chemokine binding. We conclude that the second extracellular loop of CCR5 is an ideal target site for the development of inhibitors of either chemokine or HIV-1 binding to CCR5.
Asunto(s)
Quimiocinas CC/química , Quimiocinas CC/metabolismo , Receptores CCR5/química , Receptores CCR5/metabolismo , Animales , Anticuerpos Bloqueadores/química , Anticuerpos Bloqueadores/farmacología , Anticuerpos Monoclonales/biosíntesis , Anticuerpos Monoclonales/química , Anticuerpos Monoclonales/farmacología , Especificidad de Anticuerpos , Unión Competitiva/inmunología , Quimiocina CCL3 , Quimiocina CCL4 , Quimiocina CCL5/inmunología , Quimiocina CCL5/fisiología , Quimiocinas CC/antagonistas & inhibidores , Proteína gp120 de Envoltorio del VIH/inmunología , Proteína gp120 de Envoltorio del VIH/metabolismo , VIH-1/inmunología , VIH-1/metabolismo , Humanos , Ligandos , Linfoma de Células T , Proteínas Inflamatorias de Macrófagos/inmunología , Proteínas Inflamatorias de Macrófagos/fisiología , Ratones , Ratones Endogámicos C57BL , Unión Proteica/inmunología , Estructura Terciaria de Proteína , Receptores CCR5/inmunología , Células Tumorales CultivadasRESUMEN
The chemokine eotaxin is unusual in that it appears to be a highly specific chemoattractant for eosinophils. Ligand-binding studies with radiolabeled eotaxin demonstrated a receptor on eosinophils distinct from the known chemokine receptors CKR-1 and -2. The distinct eotaxin binding site on human eosinophils also bound RANTES (regulated on activation T expressed and secreted) and monocyte chemotactic protein (MCP)3. We have now isolated a cDNA from eosinophils, termed CKR-3, with significant sequence similarity to other well characterized chemokine receptors. Cells transfected with CKR-3 cDNA bound radiolabeled eotaxin specifically and with high affinity, comparable to the binding affinity observed with eosinophils. This receptor also bound RANTES and MCP-3 with high affinity, but not other CC or CXC chemokines. Furthermore, receptor transfectants generated in a murine B cell lymphoma cell line migrated in transwell chemotaxis assays to eotaxin, RANTES, and MCP-3, but not to any other chemokines. A monoclonal antibody recognizing CKR-3 was used to show that eosinophils, but not other leukocyte types, expressed this receptor. This pattern of expression was confirmed by Northern blot with RNA from highly purified leukocyte subsets. The restricted expression of CKR-3 on eosinophils and the fidelity of eotaxin binding to CKR-3, provides a potential mechanism for the selective recruitment and migration of eosinophils within tissues.
Asunto(s)
Quimiocinas CC , Citocinas/farmacología , Eosinófilos/inmunología , Receptores de Quimiocina , Receptores de Citocinas/fisiología , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales , Secuencia de Bases , Quimiocina CCL11 , Quimiocina CCL4 , Quimiocina CCL5/farmacología , Quimiocina CCL7 , Factores Quimiotácticos Eosinófilos/metabolismo , Quimiotaxis de Leucocito , Clonación Molecular , Secuencia Conservada , Citocinas/metabolismo , Cartilla de ADN , Humanos , Linfoma de Células B , Proteínas Inflamatorias de Macrófagos , Ratones , Datos de Secuencia Molecular , Proteínas Quimioatrayentes de Monocitos/farmacología , Monocinas/farmacología , Reacción en Cadena de la Polimerasa , Receptores CCR3 , Receptores de Citocinas/biosíntesis , Receptores de Citocinas/química , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido , Transfección , Células Tumorales CultivadasRESUMEN
Several chemoattractant receptors can support agonist-induced, integrin-dependent arrest of rolling neutrophils in inflamed venules in vivo, as well as subsequent crawling into tissues. It has been hypothesized that receptors of the Galpha(i)-linked chemoattractant subfamilies, especially receptors for chemokines, may mediate parallel activation-dependent arrest of homing lymphocyte subsets. However, although several chemokines can attract subsets of B or T cells, robust chemoattractant triggering of resting lymphocyte adhesion to vascular ligands has not been observed. To study the biology of individual leukocyte chemoattractant receptors in a defined lymphoid environment, mouse L1/2 pre-B cells and/or human Jurkat T cells were transfected with alpha (IL-8 receptor A) or beta (MIP-1alpha/CC-CKR-1) chemokine receptors, or with the classical chemoattractant C5a (C5aR) or formyl peptide receptors (fPR). All receptors supported robust agonist-dependent alpha4beta1 integrin-mediated adhesion of lymphocytes to VCAM-1. L1/2 cells cotransfected with fPR and beta7 integrin were also induced to bind MAdCAM-1, suggesting common mechanisms coupling chemoattractant receptors to activation of distinct integrins. Adhesion was rapid but transient, with spontaneous reversion to unstimulated levels within 5 min after peak binding. When observed under flow conditions, alpha4beta1-mediated arrest occurred within seconds after initiation of contact and rolling of IL-8RA transfectants on VCAM-1/IL-8 co-coated surface; and arrest reversed spontaneously after a mean of 5 min with a return to rolling behavior. Each of the receptors also conferred agonist-specific chemotaxis; however, whereas strong adhesion required simultaneous occupancy of many receptors with maximal responses above the Kd, chemotaxis in each case was suppressed at high agonist concentrations. The findings indicate that alpha and beta chemokine as well as classical chemoattractant receptors can trigger robust adhesion as well as directed migration of lymphoid cells, but that the requirements for and kinetics of adhesion triggering and chemotaxis are distinct, thus permitting their independent regulation. They suggest that the discordance between proadhesive and chemoattractant responses of circulating lymphocytes to many chemokines may reflect quantitative aspects of receptor expression and/or coupling rather than qualitative differences in receptor signaling.
Asunto(s)
Quimiocinas/fisiología , Quimiotaxis de Leucocito , Cadenas beta de Integrinas , Linfocitos/fisiología , Receptores de Superficie Celular/fisiología , Animales , Antígenos CD/fisiología , Secuencia de Bases , Adhesión Celular , Proteínas de Unión al GTP/fisiología , Humanos , Integrina alfa4 , Integrina beta1/fisiología , Integrinas/fisiología , Ratones , Datos de Secuencia Molecular , Receptores de Formil Péptido , Receptores Inmunológicos/fisiología , Receptores de Interleucina/fisiología , Receptores de Interleucina-8A , Receptores de Péptidos/fisiología , Proteínas Recombinantes , Transducción de Señal , Molécula 1 de Adhesión Celular Vascular/fisiologíaRESUMEN
CD44 is a ubiquitous surface molecule that exists as a number of isoforms, generated by alternative splicing of 10 "variant" exons. Little is known about the expression and function of the variant isoforms, except that certain isoforms may play a role in cancer metastasis. We produced mAbs against CD44 variant regions encoded by exons 4v, 6v, and 9v, by immunizing mice with a fusion protein spanning variant exons 3v to 10v. A comprehensive analysis of human tissues revealed that CD44 variant isoforms were expressed widely throughout the body, principally by epithelial cells. However there was differential expression of CD44 variant exons by different epithelia. Most epithelia expressed exon 9v, but much fewer expressed 6v or 4v. The regions of epithelia that expressed the highest levels of the variant isoforms were the generative cells, particularly the basal cells of stratified squamous epithelium, and of glandular epithelium. CD44 variant isoforms were also expressed differentially by leukocytes, with CD44-9v expressed at very low levels and CD44-6v and 4v virtually absent. However, CD44-9v and CD44-6v were the main variants that were transiently upregulated on T cells after mitogenic stimulation and on myelomonocytic cell lines by TNF alpha and IFN gamma treatment. Some epithelial cell lines could preferentially upregulate CD44-6v upon IFN gamma incubation. These results show that CD44 variant isoforms are expressed much more widely than first appreciated, and that expression of the variant isoforms on some cell types can be modulated by particular cytokines.
Asunto(s)
Anticuerpos Monoclonales/inmunología , Proteínas Portadoras/metabolismo , Receptores de Superficie Celular/metabolismo , Receptores Mensajeros de Linfocitos/metabolismo , Secuencia de Aminoácidos , Modulación Antigénica , Secuencia de Bases , Proteínas Portadoras/química , Proteínas Portadoras/inmunología , Línea Celular , Cartilla de ADN/química , Epitelio/inmunología , Expresión Génica , Humanos , Receptores de Hialuranos , Interferón gamma/farmacología , Activación de Linfocitos , Datos de Secuencia Molecular , Monocitos/metabolismo , Péptidos/química , Péptidos/inmunología , ARN Mensajero/genética , Receptores de Superficie Celular/química , Receptores de Superficie Celular/inmunología , Receptores Mensajeros de Linfocitos/química , Receptores Mensajeros de Linfocitos/inmunología , Proteínas Recombinantes , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
There is growing evidence that T helper cell subsets (TH1 and TH2) can be differentially recruited to promote different types of inflammatory reactions. Murine TH1 but not TH2 cells are recruited through P- and E-selectin into inflamed tissues, where they induce delayed-type hypersensitivity reactions. The human eotaxin-receptor CCR3, originally described on eosinophils and basophils, was also found to be expressed by TH2 cells. An antibody to CCR3 was used to isolate T cells from peripheral blood that give rise to TH2-polarized cell lines and to identify TH2 cells derived from naïve T cells in vitro. Eotaxin stimulated increases in intracellular calcium and chemotaxis of CCR3(+) T cells. The attraction of TH2 cells by eotaxin could represent a key mechanism in allergic reactions, because it promotes the allergen-driven production of interleukin-4 and interleukin-5 necessary to activate basophils and eosinophils.
Asunto(s)
Quimiocinas CC , Citocinas/farmacología , Receptores de Quimiocina , Receptores de Citocinas/metabolismo , Células Th2/metabolismo , Células Th2/fisiología , Adulto , Calcio/metabolismo , Línea Celular , Separación Celular , Quimiocina CCL11 , Quimiotaxis de Leucocito , Células Clonales , Citocinas/metabolismo , Humanos , Interferón-alfa/farmacología , Interferón gamma/biosíntesis , Interleucina-3/biosíntesis , Interleucina-4/biosíntesis , Receptores CCR3 , Factor de Crecimiento Transformador beta/farmacologíaRESUMEN
OBJECTIVE: To investigate the association between haplotypes in the 5' regulatory region of the B-lymphocyte activating factor (BAFF) gene, disease susceptibility and serum BAFF (s-BAFF) levels in Caucasian primary SS (pSS) patients. METHODS: Case-control study in an established pSS cohort with PCR-RFLP genotyping for four SNPs (-2841 T-->C, -2704 T-->C, -2701 T-->A, -871 C-->T), which tag a haplotype block in the 5' regulatory region of the BAFF gene and s-BAFF determination by ELISA. RESULTS: s-BAFF levels were elevated in Ro/La-positive pSS patients (n = 85, 1770 pg/ml) compared with both Ro/La-negative pSS patients (n = 27, 1193 pg/ml) and controls (n = 59, 1171 pg/ml), P < 0.001. s-BAFF increased with diversification of the anti-Ro/La antibody response, but was not correlated with age, RF or immunoglobulin G levels. There were four common BAFF haplotypes. While the CTAT haplotype was associated with Ro/La-positive pSS [odds ratio (OR) 2.6; 95% CI 1.7, 4.1; P = 0.00004], the TTTT haplotype was associated with elevated s-BAFF in autoantibody-positive pSS (n = 85; 88% females; P = 0.008). The shared -871 T allele had no independent contribution to disease susceptibility or s-BAFF. CONCLUSIONS: Disease susceptibility for Ro/La-positive pSS is increased with the CTAT haplotype, but not associated with high s-BAFF levels. Elevated s-BAFF levels in pSS are associated with the TTTT haplotype and may be a secondary phenomenon in Ro/La-positive pSS. While both haplotypes carry the -871 T allele, this allele is not independently associated with disease susceptibility.
Asunto(s)
Autoanticuerpos/sangre , Factor Activador de Células B/genética , Polimorfismo de Nucleótido Simple , Síndrome de Sjögren/genética , Anticuerpos Antinucleares/sangre , Autoantígenos/inmunología , Factor Activador de Células B/sangre , Estudios de Casos y Controles , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Ribonucleoproteínas/inmunología , Síndrome de Sjögren/inmunología , Antígeno SS-BRESUMEN
The discovery of a new and unusual member of the chemokine family illustrates the importance of chemoattractant diversity in the regulation of leukocyte movement through the body. The chemokines are now divisible into four clearly defined subgroups on the basis of structural and functional properties.
Asunto(s)
Quimiocinas CX3C , Quimiocinas/clasificación , Linfocinas/clasificación , Proteínas de la Membrana/clasificación , Sialoglicoproteínas/clasificación , Quimiocina CX3CL1 , Quimiocinas/fisiología , Quimiotaxis de Leucocito , Linfocinas/fisiología , Proteínas de la Membrana/fisiología , Receptores de Citocinas/fisiología , Sialoglicoproteínas/fisiologíaRESUMEN
BACKGROUND: The chemokine eotaxin is produced at sites of allergic inflammation, binds selectively to the chemokine receptor CCR3 and attracts eosinophil and basophil leukocytes, which express high numbers of this receptor. Responses of T lymphocytes to eotaxin have not been reported so far. We have investigated the expression of CCR3 in T lymphocytes and analysed the properties and in vivo distribution of T lymphocytes expressing this receptor. RESULTS: In search of chemokine receptors with selective expression in T lymphocytes, we have isolated multiple complementary DNAs (cDNAs) encoding CCR3 from a human CD4+ T-cell cDNA library. T-lymphocyte clones with selectivities for protein and non-protein antigens were analysed for expression of CCR3 and production of Th1- and Th2-type cytokines. Of 13 clones with surface CCR3, nine secreted enhanced levels of interleukin-4 and/or interleukin-5, indicating that CCR3 predominates in Th2-type lymphocytes. CCR3+ T lymphocytes readily migrated in response to eotaxin, and showed the characteristic changes in cytosolic free calcium. Immunostaining of contact dermatitis, nasal polyp and ulcerative colitis tissue showed that CCR3+ T lymphocytes are recruited together with eosinophils and, as assessed by flow cytometry, a large proportion of CD3+ cells extracted from the inflamed skin tissue were CCR3+. By contrast, CCR3+ T lymphocytes were absent from tissues that lack eosinophils, as demonstrated for normal skin and rheumatoid arthritis synovium. CONCLUSIONS: We show that T lymphocytes co-localizing with eosinophils at sites of allergic inflammation express CCR3, suggesting that eotaxin/CCR3 represents a novel mechanism of T-lymphocyte recruitment. These cells are essential in allergic inflammation, as mice lacking mature T lymphocytes were insensitive to allergen challenge. Surface CCR3 may mark a subset of T lymphocytes that induce eosinophil mobilization and activation through local production of Th2-type cytokines.
Asunto(s)
Eosinófilos/metabolismo , Receptores de Quimiocina/biosíntesis , Linfocitos T/metabolismo , Movimiento Celular/inmunología , Células Clonales , Clonación Molecular , Colitis Ulcerosa/inmunología , Colitis Ulcerosa/metabolismo , Colitis Ulcerosa/patología , Dermatitis por Contacto/inmunología , Dermatitis por Contacto/metabolismo , Dermatitis por Contacto/patología , Eosinófilos/patología , Expresión Génica , Humanos , Pólipos Nasales/inmunología , Pólipos Nasales/metabolismo , Pólipos Nasales/patología , Receptores CCR3 , Receptores de Quimiocina/sangre , Receptores de Quimiocina/genética , Linfocitos T/química , Linfocitos T/patologíaRESUMEN
Chemokines are widely hypothesized to stimulate firm adhesion of leukocytes on endothelium in shear flow. Thus far, this has been demonstrated experimentally for exogenously added chemoattractants, but not for those released by endothelium. We found that human umbilical cord endothelial cells (HUVEC) stimulated with TNF-alpha and IFN-gamma secreted eosinophil chemoattractants into the culture supernatant. This material induced transendothelial chemotaxis, stimulated eosinophil binding to purified intercellular adhesion molecule 1, and augmented binding to purified vascular cell adhesion molecule 1 in a 3-min static assay. Chemotaxis and stimulation of adhesion were abrogated completely by the pretreatment of eosinophils with an mAb to the C-C chemokine receptor 3 (CCR3). Eosinophils accumulated efficiently on HUVEC stimulated with TNF-alpha and IFN-gamma in shear flow at 1.5 dyn/cm2. CCR3 mAb slightly but significantly reduced eosinophil arrest and accumulation, by preventing development of firm adhesion by some of the tethered eosinophils, so that they detached within 30 s after the initial tethering. In the presence of mAb to the alpha4 integrin subunit, the effect of CCR3 mAb was more prominent, and approximately half of eosinophil arrest and accumulation was abolished. Inhibition by CCR3 mAb in the presence of beta2 integrin mAb was similar to that in control eosinophils. This is the first evidence that endothelial cell-derived chemokines can activate firm adhesion through alpha4 and beta2 integrins even in the presence of shear flow.
Asunto(s)
Endotelio Vascular/fisiología , Eosinófilos/fisiología , Receptores de Quimiocina/fisiología , Antígenos CD/metabolismo , Antígenos CD18/metabolismo , Adhesión Celular/fisiología , Quimiotaxis de Leucocito/fisiología , Endotelio Vascular/efectos de los fármacos , Humanos , Inflamación , Integrina alfa4 , Integrinas/metabolismo , Molécula 1 de Adhesión Intercelular/metabolismo , Interferón gamma/farmacología , Factor de Activación Plaquetaria/antagonistas & inhibidores , Receptores CCR3 , Reología , Factor de Necrosis Tumoral alfa/farmacología , Molécula 1 de Adhesión Celular Vascular/metabolismo , Factores de Virulencia de Bordetella/farmacologíaRESUMEN
Chemokines bind and signal through G-protein coupled seven transmembrane receptors. Various chemokine receptors are expressed on leukocytes, and these may impart selective homing of leukocyte subsets to sites of inflammation. Human eosinophils express the eotaxin receptor, CCR3, but respond to a variety of CC chemokines apart from eotaxin, including RANTES, monocyte chemotactic protein (MCP)-2, MCP-3, and MCP-4. Here we describe a mAb, 7B11, that is selective for CCR3 and has the properties of a true receptor antagonist. 7B11 blocked binding of various radiolabeled chemokines to either CCR3 transfectants, or eosinophils. Pretreatment of eosinophils with this mAb blocked chemotaxis and calcium flux induced by all CCR3 ligands. In all individuals examined, including allergic and eosinophilic donors, > 95% of the response of eosinophils to eotaxin, RANTES, MCP-2, MCP-3, and MCP-4 was shown to be mediated through CCR3. The IL-8 receptors, particularly CXCR2, were induced on IL-5 primed eosinophils, however these eosinophils responded to CC chemokines in the same manner as unprimed eosinophils. These results demonstrate the importance of CCR3 for eosinophil responses, and the feasibility of completely antagonizing this receptor.
Asunto(s)
Quimiocinas CC , Quimiocinas/metabolismo , Eosinófilos/metabolismo , Receptores de Quimiocina , Receptores de Citocinas/metabolismo , Anticuerpos Monoclonales/farmacología , Antígenos CD/metabolismo , Calcio/metabolismo , Quimiocina CCL11 , Quimiocina CCL5/antagonistas & inhibidores , Quimiocina CCL5/metabolismo , Citocinas/antagonistas & inhibidores , Citocinas/metabolismo , Humanos , Interleucina-5/metabolismo , Proteínas Quimioatrayentes de Monocitos/antagonistas & inhibidores , Proteínas Quimioatrayentes de Monocitos/metabolismo , Unión Proteica/efectos de los fármacos , Receptores CCR3 , Receptores de Citocinas/antagonistas & inhibidores , Receptores de Citocinas/inmunología , Receptores de Interleucina/metabolismo , Receptores de Interleucina-8ARESUMEN
Eosinophil leukocytes express high numbers of the chemokine receptor CCR3 which binds eotaxin, monocyte chemotactic protein (MCP)-4, and some other CC chemokines. In this paper we show that CCR3 is also highly expressed on human blood basophils, as indicated by Northern blotting and flow cytometry, and mediates mainly chemotaxis. Eotaxin and MCP-4 elicited basophil migration in vitro with similar efficacy as regulated upon activation normal T cells expressed and secreted (RANTES) and MCP-3. They also induced the release of histamine and leukotrienes in IL-3-primed basophils, but their efficacy was lower than that of MCP-1 and MCP-3, which were the most potent stimuli of exocytosis. Pretreatment of the basophils with a CCR3-blocking antibody abrogated the migration induced by eotaxin, RANTES, and by low to optimal concentrations of MCP-4, but decreased only minimally the response to MCP-3. The CCR3-blocking antibody also affected exocytosis: it abrogated histamine and leukotriene release induced by eotaxin, and partially inhibited the response to RANTES and MCP-4. In contrast, the antibody did not affect the responses induced by MCP-1, MCP-3, and macrophage inflammatory protein-1alpha, which may depend on CCR1 and CCR2, two additional receptors detected by Northern blotting with basophil RNA. This study demonstrates that CCR3 is the major receptor for eotaxin, RANTES, and MCP-4 in human basophils, and suggests that basophils and eosinophils, which are the characteristic effector cells of allergic inflammation, depend largely on CCR3 for migration towards different chemokines into inflamed tissues.
Asunto(s)
Basófilos/fisiología , Quimiocinas CC , Quimiocinas/farmacología , Citocinas/farmacología , Proteínas Quimioatrayentes de Monocitos/farmacología , Receptores de Quimiocina , Receptores de Citocinas/fisiología , Quimiocina CCL11 , Quimiocina CCL5/farmacología , Quimiotaxis , Liberación de Histamina , Humanos , Receptores CCR3 , Receptores de Citocinas/análisisRESUMEN
T cells infiltrating inflammatory sites are usually of the activated/memory type. The precise mechanism for the positioning of these cells within tissues is unclear. Adhesion molecules certainly play a role; however, the intricate control of cell migration appears to be mediated by numerous chemokines and their receptors. Particularly important chemokines for activated/memory T cells are the CXCR3 ligands IP-10 and Mig and the CCR5 ligands RANTES, macrophage inflammatory protein-1alpha, and macrophage inflammatory protein-1beta. We raised anti-CXCR3 mAbs and were able to detect high levels of CXCR3 expression on activated T cells. Surprisingly, a proportion of circulating blood T cells, B cells, and natural killer cells also expressed CXCR3. CCR5 showed a similar expression pattern as CXCR3, but was expressed on fewer circulating T cells. Blood T cells expressing CXCR3 (and CCR5) were mostly CD45RO+, and generally expressed high levels of beta1 integrins. This phenotype resembled that of T cells infiltrating inflammatory lesions. Immunostaining of T cells in rheumatoid arthritis synovial fluid confirmed that virtually all such T cells expressed CXCR3 and approximately 80% expressed CCR5, representing high enrichment over levels of CXCR3+ and CCR5+ T cells in blood, 35 and 15%, respectively. Analysis by immunohistochemistry of various inflamed tissues gave comparable findings in that virtually all T cells within the lesions expressed CXCR3, particularly in perivascular regions, whereas far fewer T cells within normal lymph nodes expressed CXCR3 or CCR5. These results demonstrate that the chemokine receptor CXCR3 and CCR5 are markers for T cells associated with certain inflammatory reactions, particularly TH-1 type reactions. Moreover, CXCR3 and CCR5 appear to identify subsets of T cells in blood with a predilection for homing to these sites.
Asunto(s)
Quimiocinas CXC , Inflamación/inmunología , Receptores CCR5/inmunología , Receptores de Quimiocina/inmunología , Subgrupos de Linfocitos T/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Biomarcadores , Quimiocina CXCL10 , Quimiocinas/inmunología , Quimiotaxis , Humanos , Memoria Inmunológica/inmunología , Leucocitos/inmunología , Activación de Linfocitos/inmunología , Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Receptores CXCR3 , Receptores de Quimiocina/biosíntesis , Líquido Sinovial/citología , Líquido Sinovial/inmunología , Subgrupos de Linfocitos T/citología , Células Tumorales CultivadasRESUMEN
The CC chemokine eotaxin, identified in guinea pigs and also recently in mice, may be a key element for the selective recruitment of eosinophils to certain inflamed tissues. Using a partial mouse eotaxin CDNA probe, the human eotaxin gene was cloned and found to be 61.8 and 63.2% identical at the amino acid level to guinea pig and mouse eotaxin. Human eotaxin protein was a strong and specific eosinophil chemoattractant in vitro and was an effective eosinophil chemoattractant when injected into the skin of a rhesus monkey. Radiolabeled eotaxin was used to identify a high affinity receptor on eosinophils (0.52 nM Kd), expressed at 4.8 x 10(4) sites per cell. This receptor also bound RANTES and monocyte chemotactic protein-3 with lower affinity, but not macrophage inflammatory protein-1 alpha. Eotaxin could desensitize calcium responses of eosinophils to RANTES and monocyte chemotactic protein-3, although RANTES was able to only partially desensitize eosinophil calcium responses to eotaxin. Immunohistochemistry on human nasal polyp with antieotaxin mAbs showed that certain leukocytes as well as respiratory epithelium were intensely immunoreactive, and eosinophil infiltration occurred at sites of eotaxin upregulation. Thus eotaxin in humans is a potent and selective eosinophil chemoattractant that is expressed by a variety cell types in certain inflammatory conditions.
Asunto(s)
Quimiocinas CC , Factores Quimiotácticos Eosinófilos/genética , Quimiotaxis de Leucocito , Citocinas/genética , Eosinófilos/fisiología , Receptores de Quimiocina , Receptores de Citocinas/metabolismo , Secuencia de Aminoácidos , Animales , Anticuerpos Monoclonales , Secuencia de Bases , Unión Competitiva , Calcio/metabolismo , Quimiocina CCL11 , Quimiocina CCL5/metabolismo , Quimiocina CCL7 , Factores Quimiotácticos Eosinófilos/inmunología , Factores Quimiotácticos Eosinófilos/metabolismo , Clonación Molecular , Citocinas/inmunología , Citocinas/metabolismo , ADN Complementario/genética , Humanos , Macaca mulatta , Masculino , Datos de Secuencia Molecular , Proteínas Quimioatrayentes de Monocitos/metabolismo , Unión Proteica , Receptores CCR3 , Homología de Secuencia de Aminoácido , Regulación hacia ArribaRESUMEN
Lymphocyte subsets home in a particular manner depending on their class, state of activation and 'allegiance' to certain tissues. Naive lymphocytes home preferentially through lymphoid tissues, whereas effector and memory cells home preferentially through non-lymphoid tissues and exist as phenotypically distinct subsets with preferential localization to gut, skin or other tissues. These migration pathways, which correlate with different functional properties of lymphocyte subsets, increase the efficiency of the immune system.